Periarticular Injection Versus Fascia Iliaca Block for Total Knee Arthroplasty
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02047331|
Recruitment Status : Completed
First Posted : January 28, 2014
Last Update Posted : January 28, 2014
|Condition or disease||Intervention/treatment||Phase|
|Total Knee Arthroplasty||Procedure: periarticular injection Procedure: fascia iliaca block||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||66 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Care Provider, Outcomes Assessor)|
|Official Title:||Multimodal Periarticular Injection Versus Fascia Iliaca Compartment Block for Total Knee Arthroplasty|
|Study Start Date :||February 2013|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||August 2013|
Active Comparator: group PI
group PI were performed periarticular drug injection during surgery.
Procedure: periarticular injection
patients were performed bupivacaine solution to the periarticular soft tissues during surgery by the surgeon.
Active Comparator: group FI
group FI were performed fascia iliaca block before surgery
Procedure: fascia iliaca block
patients were performed fascia iliaca block with bupivacaine solution before surgery.
- Postoperative pain scores of periarticular injection and fascia block for total knee arthroplasty [ Time Frame: postoperative 24 hours ]Patients were assigned in two groups to perform either periarticular injection (group PI) and fascia block ( group FB). They were accessed by visual analog scale. The aim was to compare the efficacy and side effects of periarticular injection and fascia block.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02047331
|Baskent University School of Medicine Adana Teaching and reserach Hospital|
|Adana, Turkey, 01250|
|Study Director:||Anis Aribogan, Prof.,MD||Baskent University School of Medicine|